Search Medical Condition
Please enter condition
Please choose location

Madrid, Getafe Clinical Trials

A listing of Madrid, Getafe clinical trials actively recruiting patients volunteers.

RESULTS

Found (726) clinical trials

This is a randomized, double-blind, placebo-controlled, multicenter phase III study. The study population will consist of approximately 1300 subjects with metastatic hormone sensitive prostate cancer (mHSPC), who will be randomized (1:1 ratio) to receive 600 mg (2 x 300 mg tablets) of darolutamide (ODM-201)/placebo twice daily with food, equivalent to ...

Phase